Tibet Cheezheng Tibetan Medicine Co Ltd Capital Reinvestment Ratio
Tibet Cheezheng Tibetan Medicine Co Ltd capital reinvestment ratio. Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Capital Reinvestment Ratio of 1.20x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥34.69 Million) in capital expenditures (CN¥41.69 Million). See Tibet Cheezheng Tibetan Medicine Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Capital reinvestment ratio of Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2025. This chart tracks Tibet Cheezheng Tibetan Medicine Co Ltd's Capital Reinvestment Ratio across 19 annual periods. See 002287 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Tibet Cheezheng Tibetan Medicine Co Ltd Capital Reinvestment Ratio by Year (2006–2025)
Tibet Cheezheng Tibetan Medicine Co Ltd capital reinvestment ratio by year from 2006 to 2025. For the full cash flow conversion analysis, see 002287 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | CN¥729.70 Million | CN¥153.08 Million | ▼ -62.5% |
| 2024 | 0.56x | CN¥456.75 Million | CN¥255.44 Million | ▲ +65.1% |
| 2023 | 0.34x | CN¥693.41 Million | CN¥234.81 Million | ▼ -64.5% |
| 2022 | 0.95x | CN¥285.69 Million | CN¥272.40 Million | ▲ +685.8% |
| 2021 | 0.12x | CN¥1.03 Billion | CN¥125.57 Million | ▼ -91.5% |
| 2020 | 1.42x | CN¥238.65 Million | CN¥338.97 Million | ▲ +1003.1% |
| 2019 | 0.13x | CN¥405.95 Million | CN¥52.27 Million | ▼ -50.1% |
| 2018 | 0.26x | CN¥499.40 Million | CN¥128.94 Million | ▼ -10.3% |
| 2017 | 0.29x | CN¥229.83 Million | CN¥66.13 Million | ▼ -37.7% |
| 2016 | 0.46x | CN¥389.20 Million | CN¥179.87 Million | ▲ +83.6% |
| 2015 | 0.25x | CN¥257.81 Million | CN¥64.90 Million | ▼ -3.9% |
| 2014 | 0.26x | CN¥310.95 Million | CN¥81.48 Million | ▼ -30.1% |
| 2013 | 0.37x | CN¥198.48 Million | CN¥74.38 Million | ▲ +3.1% |
| 2012 | 0.36x | CN¥169.67 Million | CN¥61.65 Million | ▼ -38.6% |
| 2010 | 0.59x | CN¥96.91 Million | CN¥57.32 Million | ▲ +531.7% |
| 2009 | 0.09x | CN¥175.58 Million | CN¥16.44 Million | ▼ -74.1% |
| 2008 | 0.36x | CN¥65.93 Million | CN¥23.79 Million | ▲ +8.2% |
| 2007 | 0.33x | CN¥91.43 Million | CN¥30.49 Million | ▼ -7.7% |
| 2006 | 0.36x | CN¥38.50 Million | CN¥13.91 Million | — |